Proteome analysis of bronchoalveolar lavage in lung diseases
- PMID: 17133372
- DOI: 10.1002/pmic.200600303
Proteome analysis of bronchoalveolar lavage in lung diseases
Abstract
The proteomic approach is complementary to genomics and enables protein composition to be investigated under various clinical conditions. Its application to the study of bronchoalveolar lavage (BAL) is extremely promising. BAL proteomic studies were initially based on two-dimensional electrophoretic separation of complex protein samples and subsequent identification of proteins by different methods. With the techniques available today it is possible to attain many different research objectives. BAL proteomics can contribute to the identification of proteins in alveolar spaces with possible insights into pathogenesis and clinical application for diagnosis, prognosis and therapy. Many proteins with different functions have already been identified in BAL. Some could be biomarkers that need to be individually confirmed by correlation with clinical parameters and validation by other methods on larger cohorts of patients. The standardization of BAL sample preparation and processing for proteomic studies is an important goal that would promote and facilitate clinical applications. Here, we review the principal literature on BAL proteomic analysis applied to the study of lung diseases.
Similar articles
-
Proteomics of bronchoalveolar lavage fluid.J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Feb 5;815(1-2):169-78. doi: 10.1016/j.jchromb.2004.10.029. J Chromatogr B Analyt Technol Biomed Life Sci. 2005. PMID: 15652807 Review.
-
Proteomic analysis in interstitial lung diseases: a review.Curr Opin Pulm Med. 2009 Sep;15(5):470-8. doi: 10.1097/MCP.0b013e32832ea4f2. Curr Opin Pulm Med. 2009. PMID: 19593140 Review.
-
Proteomics of cerebrospinal fluid: methods for sample processing.Methods Mol Biol. 2008;425:53-66. doi: 10.1007/978-1-60327-210-0_5. Methods Mol Biol. 2008. PMID: 18369886
-
Biomarkers for cystic fibrosis lung disease: application of SELDI-TOF mass spectrometry to BAL fluid.J Cyst Fibros. 2008 Sep;7(5):352-8. doi: 10.1016/j.jcf.2007.12.005. Epub 2008 Feb 1. J Cyst Fibros. 2008. PMID: 18243068
-
Sample preparation of bronchoalveolar lavage fluid.Methods Mol Biol. 2008;425:67-75. doi: 10.1007/978-1-60327-210-0_6. Methods Mol Biol. 2008. PMID: 18369887
Cited by
-
Robust substrate profiling method reveals striking differences in specificities of serum and lung fluid proteases.Biotechniques. 2011 Aug;51(2):95-104. doi: 10.2144/000113717. Biotechniques. 2011. PMID: 21806553 Free PMC article.
-
Glycoproteomics using fluid-based specimens in the discovery of lung cancer protein biomarkers: promise and challenge.Proteomics Clin Appl. 2013 Jan;7(1-2):55-69. doi: 10.1002/prca.201200105. Proteomics Clin Appl. 2013. PMID: 23112109 Free PMC article. Review.
-
Molecular analysis of serum and bronchoalveolar lavage in a mouse model of influenza reveals markers of disease severity that can be clinically useful in humans.PLoS One. 2014 Feb 5;9(2):e86912. doi: 10.1371/journal.pone.0086912. eCollection 2014. PLoS One. 2014. PMID: 24505273 Free PMC article.
-
Oxidant/Antioxidant Disequilibrium in Idiopathic Pulmonary Fibrosis Pathogenesis.Inflammation. 2020 Feb;43(1):1-7. doi: 10.1007/s10753-019-01059-1. Inflammation. 2020. PMID: 31297749 Review.
-
Yiqi Yangyin Huoxue Method in Treating IdiopathicPulmonary Fibrosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Evid Based Complement Alternat Med. 2020 Oct 3;2020:8391854. doi: 10.1155/2020/8391854. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 33062025 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical